EQUITY-BASED COMPENSATION EXPENSE (Tables)

9 Months Ended

Sep. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Options Roll Forward

The following table summarizes stock option activity during the nine months ended September 30, 2025:

	Options Outstanding
(in thousands, except per share amounts)	Number of Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value(1)
Outstanding, December 31, 2024	3,252	$	1.78	3.0	$	—
Granted	9,936	0.36
Exercised	(171)	0.35			$	61
Forfeited	(107)	1.05
Expired	(92)	1.50
Outstanding, September 30, 2025	12,818	$	0.70	1.9	$	3,207
Exercisable at September 30, 2025	3,866	$	1.45	2.1	$	351

(1)Based on the amount by which the closing market price of our Class A common stock exceeds the exercise price on each date indicated.

Schedule of Unvested Restricted Stock Units Roll Forward

The following table summarizes the RSU activity during the nine months ended September 30, 2025:

	Number of Shares (in thousands)	Weighted-Average Grant Date Fair Value per Share
Unvested, December 31, 2024	5,898	$	1.06
Granted	225	0.40
Vested(1)	(1,536)	1.19
Forfeited	(854)	1.19
Unvested, September 30, 2025	3,733	$	0.94

(1)Includes 439 vested shares that were withheld to cover tax obligations and were subsequently cancelled.

Schedule of Equity-based Compensation Expense

The following table details the equity-based compensation expense by type of award for the periods presented:

	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2025		2024		2025		2024
RSUs	$	466	$	(287)	$	1,547	$	14,575
Stock Options	340		92		398		1,230
Total equity-based compensation expense	$	806	$	(195)	$	1,945	$	15,805